Oncology Pharma Inc.
ONPH - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.37M
Close$
$-0.02
171.4% downside
Current Fair Value
171.4% downsideOvervalued by 171.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.37 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0 |
| Beta | -0.13 |
| Outstanding Shares | 82,164,642 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -705.88 |
|---|---|
| PEG | 708.16 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Oncology Pharma Inc.
1 employees
CEO: George Malesek
Oncology Pharma Inc. is a pharmaceutical firm specializing in oncology, dedicated to the development, manufacturing, and commercialization of therapeutic agents. The company has a collaborative and licensing agreement with Kalos Therapeu...